Adam S. Arterbery

Adam S. Arterbery

Auto-generated profile, based on publicly available information

Adam S. Arterbery

The Jackson Laboratory for Genomic Medicine , Farmington, CT

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2016 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
AAAdam S. Arterbery
Adam S. Arterbery
AOAwo Osafo-Addo
Awo Osafo-Addo
YAYaron Avitzur
Yaron Avitzur
MCMaria Ciarleglio
Maria Ciarleglio
YDYanhong Deng
Yanhong Deng
UEUdeme Ekong
Udeme Ekong
A subset of human regulatory T cells (Tregs) can secrete IFN-γ or IL-17, and thus share features of TH1 or TH17 effector cells and lose suppressive function. The main factors driving this differentiation of Tregs toward a proinflammatory phenotype include IL-12 for TH1-like and IL-6 for TH17-type Tregs. In this study we show that Tregs of patients with de novo autoimmune hepatitis (dAIH) display increased frequencies of proinflammatory IFN-γ and IL-17 cytokines. Irrespective of a fully demethylated FOXP3 locus, Tregs of subjects with dAIH are functionally impaired. In line with the observed Treg phenotype, we detected the presence of two dominant cytokines (IL-12 and IL-6) clustering with CD68+ monocyte/macrophage cells in livers of subjects with dAIH, and isolated monocytes of subjects with dAIH secrete high levels of proinflammatory IL-12 and IL-6, suggesting that this inflammatory milieu is key for functional impairment of Tregs. Importantly, the blockade of IFN-γ partially restores suppressive function of Tregs of subjects with dAIH, indicating that monocyte/macrophage-derived triggers might play a central role in Treg dysfunction and pathogenesis of dAIH.

18 January 2026 in medRxiv
Verified
Preprint
Open access
PDF file
AAAdam S Arterbery
Adam S Arterbery
MGMichael A Gargano
Michael A Gargano
ABAnita Bagley
Anita Bagley
JSJagadish Chandrabose Sundaramurthi
Jagadish Chandrabose Sundaramurthi
LRLauren Rekerle
Lauren Rekerle
PRPeter N. Robinson
Peter N. Robinson
Disease-causing genetic variants can be found in a subset of individuals with cerebral palsy (CP), with variants deemed causal of CP having been published for at least 515 genes. We develop a statistical approach that treats CP as a phenotypic feature for which some genetic disorders confer an increased risk. Based on comprehensive literature curation we show that the null hypothesis of no CP association can be rejected for only 89 of the 515 genes. We applied these findings to the analysis of a cohort of 460 children diagnosed with CP in the Shriner Children's network. We identified pathogenic or likely pathogenic (P/LP) variants in 60 genes in 15.8% of the children. Only 16 of the 60 genes had significant evidence for CP association in our literature analysis. Our results suggest that a stratified approach to attributing causality to genetic variants in CP could support precision genomic medicine for affected individuals.

3 September 2026 in The American Journal of Human Genetics
Verified
Journal Article
Open access
AAAdam S. Arterbery
Adam S. Arterbery
MGMichael A. Gargano
Michael A. Gargano
ABAnita Bagley
Anita Bagley
JSJagadish Chandrabose Sundaramurthi
Jagadish Chandrabose Sundaramurthi
LRLauren Rekerle
Lauren Rekerle
PRPeter N. Robinson
Peter N. Robinson

16 June 2026 in British Journal of Dermatology
Verified
Journal Article
Closed access
ECEdwin Cuperus
Edwin Cuperus
SPSuzanne G M A Pasmans
Suzanne G M A Pasmans
HHHenry L Han
Henry L Han
AAAdam S Arterbery
Adam S Arterbery
DDDaniel Danis
Daniel Danis
MGMariëlle E van Gijn
Mariëlle E van Gijn
This study brings the Human Phenotype Ontology into dermatology, refining and expanding its use for Netherton syndrome (SPINK5-sEDD). The updated terms significantly boost diagnostic performance and enhance clinical phenotyping. It highlights the promise of ontology-based tools for rare skin diseases.